Alpine Immune Sciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]

Capstone Investment Advisors LLC purchased a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 25,289 shares of the biotechnology company’s stock, valued at approximately $482,000. Other institutional investors also […]

Monashee Investment Management LLC purchased a new position in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 74,792 shares of the biotechnology company’s stock, valued at approximately $1,426,000. A number of other institutional investors […]

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising non-opioid painkillers.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Alpine Immune Sciences, Inc. to Vertex...